FLUTENSIF

This brand name is authorized in Estonia, Lithuania.

Active ingredients

The drug FLUTENSIF contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII F089I0511L - INDAPAMIDE
 

Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action.
 
Read more about Indapamide
2
UNII 864V2Q084H - AMLODIPINE BESYLATE
 

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
 
Read more about Amlodipine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C08GA02 C Cardiovascular system → C08 Calcium channel blockers → C08G Calcium channel blockers and diuretics → C08GA Calcium channel blockers and diuretics
Discover more medicines within C08GA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1588282, 1588293, 1588305, 1588316, 1588327, 1588338, 1588349, 1588350, 1588361, 1588372, 1588383, 1588394
LT Valstybinė vaistų kontrolės tarnyba 1066879, 1066880, 1066881, 1066882, 1071717, 1071718, 1071719, 1071720, 1071721, 1071722, 1071723, 1071724

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈